ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.

Jinlu Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.